Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MS4A6A |
| Upstream (Parents) |
|---|
| (<<) GIMAP4 → MS4A6A |
| (<<) C1QA → MS4A6A |
| (<<) CD14 → MS4A6A |
| Downstream (Children) |
|---|
| MS4A6A → CPVL (>>) |
| MS4A6A → LY86 (>>) |
| MS4A6A → LIPA (>>) |
| MS4A6A → GIMAP6 (>>) |
| MS4A6A → LPAR6 (>>) |
| MS4A6A → TCN2 (>>) |
| MS4A6A → CSTA (>>) |
| MS4A6A → GIMAP4 (>>) |
| MS4A6A → MAFB (>>) |
| MS4A6A → RGL1 (>>) |
| MS4A6A → SIGLEC1 (>>) |
| MS4A6A → HLA-DPA1 (>>) |
| MS4A6A → C1QA (>>) |
| MS4A6A → EMR1 (>>) |
| MS4A6A → C1QB (>>) |
| MS4A6A → CPM (>>) |
| MS4A6A → MRC1L1///MRC1 (>>) |
| MS4A6A → CLIC2 (>>) |
| MS4A6A → FOLR2 (>>) |
| MS4A6A → UBE2L6 (>>) |
